Crossmark

What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study

Crossref DOI link: https://doi.org/10.1038/s41416-023-02268-0

Published Online: 2023-05-24

Published Print: 2023-08-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McWilliams, Lorna https://orcid.org/0000-0002-6414-2732
Ruane, Helen

Ulph, Fiona https://orcid.org/0000-0003-3590-6542
Woof, Victoria G.

Harrison, Fiona

Evans, D. Gareth https://orcid.org/0000-0002-8482-5784
French, David P. https://orcid.org/0000-0002-7663-7804
Funding

Funding for this research was provided by:

DH | NIHR | Programme Grants for Applied Research (RP-PG-1214-20016, RP-PG-1214-20016, RP-PG-1214-20016, RP-PG-1214-20016, RP-PG-1214-20016, RP-PG-1214-20016, RP-PG-1214-20016)

DH | National Institute for Health Research (IS-BRC-1215-20007, IS-BRC-1215-20007, IS-BRC-1215-20007)
License Information

Text and Data Mining valid from 2023-05-24

Version of Record valid from 2023-05-24
More Information

Article History

Received: 2 August 2022

Revised: 30 March 2023

Accepted: 3 April 2023

First Online: 24 May 2023

Competing interests

: The authors declare no competing interests. DGE reports consultancy for AstraZeneca and Everything Genetic.

: Ethical approval was received from Northwest—Greater Manchester East Research Ethics Committee (18/NW/0856), and the study was carried out following the Good Clinical Practice principles and relevant regulations. All participants provided informed consent prior to taking part in an interview.

: There is no information that could lead to the identification of study participants. Participants provided informed consent to the use of anonymised quotes in publications and anonymised demographic information to describe the sample.

Document is current

Any future updates will be listed below